Cystic Fibrosis Clinical Trials

Birmingham : UAB/CHS Cystic Fibrosis Center

I Change Adherence & Raise Expectations

Birmingham : Site Reference ID/Investigator# 78920

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Birmingham : University of Alabama at Birmingham

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Birmingham : The University of Alabama at Birmingham

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Birmingham :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

View More »

Birmingham :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Birmingham : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Mobile :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Anchorage : Site Reference ID/Investigator# 79256

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Phoenix : Phoenix Children's Hospital

I Change Adherence & Raise Expectations

Tucson : University of Arizona Medical Center

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Tucson :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Little Rock :

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

Little Rock : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Little Rock : Site Reference ID/Investigator# 79265

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

La Jolla : University of California - San Diego

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Los Angeles : University of Southern California

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Oakland : Kaiser Permanente Medical Care Program

I Change Adherence & Raise Expectations

Oakland : Site Reference ID/Investigator# 79295

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Oakland : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

View More »

Palo Alto : Updated

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Palo Alto :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Aurora : Site Reference ID/Investigator# 79277

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Aurora : Children's Hospital Colorado

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Denver : Site Reference ID/Investigator# 76784

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Denver : National Jewish Health

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Denver :

Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function

View More »

Denver : National Jewish Hospital

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Hartford : Connecticut Children's Medical Center

I Change Adherence & Raise Expectations

Hartford :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

New Haven : Site Reference ID/Investigator# 78940

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Wilmington : Site Reference ID/Investigator# 78945

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Wilmington : Alfred I. duPont Hospital for Children

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Washington : Site Reference ID/Investigator# 79373

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Washington DC : Children's National Medical Center

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Altamonte Springs : Site Reference ID/Investigator# 76776

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Altamonte Springs : Central Florida Pulmonary Group

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Gainesville : Site Reference ID/Investigator# 76790

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Gainesville : Site Reference ID/Investigator# 78928

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Jacksonville : Site Reference ID/Investigator# 78898

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

View More »

Miami : University of Miami

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Orlando : Site Reference ID/Investigator# 78917

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Orlando : Site Reference ID/Investigator# 96075

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Orlando : Nemours Children's Clinic - Orlando

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

St. Petersburg : Site Reference ID/Investigator# 79264

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Tampa : Site Reference ID/Investigator# 76783

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Tampa :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Atlanta : Site Reference ID/Investigator# 79394

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Atlanta : Children's Healthcare of Atlanta at Scottish Rite

Prevention of Cystic Fibrosis Diabetes

Atlanta : Emory University

Prevention of Cystic Fibrosis Diabetes

Augusta : Site Reference ID/Investigator# 79395

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Boise : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Chicago : Children's Memorial Hospital

I Change Adherence & Raise Expectations

Chicago : Site Reference ID/Investigator# 79296

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Chicago :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Chicago : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Evansville :

A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects

Indianapolis : Riley Hospital for Children

I Change Adherence & Raise Expectations

Indianapolis : Site Reference ID/Investigator# 78903

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Indianapolis : Riley Hospital for Children

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Indianapolis :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

View More »

Indianapolis :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Iowa City :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Kansas City : University of Kansas Medical Center

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Lexington :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

New Orleans : Site Reference ID/Investigator# 78916

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Portland : Maine Medical Center

I Change Adherence & Raise Expectations

Portland : Site Reference ID/Investigator# 78894

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Baltimore : Johns Hopkins University

Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis

Baltimore : Site Reference ID/Investigator# 78893

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Baltimore :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Boston : Children's Hospital Boston

I Change Adherence & Raise Expectations

Boston : Site Reference ID/Investigator# 78895

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Boston : Site Reference ID/Investigator# 79254

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Boston : Site Reference ID/Investigator# 79276

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Boston : Boston Children's Hospital

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

View More »

Boston : Updated

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Boston : Children's Hospital Boston

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Boston : Children's Hosptital, Boston

Structure and Function of Salivary Proteins

Boston :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Boston :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Boston : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Boston :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Worcester : Site Reference ID/Investigator# 78954

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Ann Arbor : University of Michigan Health System

I Change Adherence & Raise Expectations

Detriot :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Detroit : Harper University Hospital

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Detroit :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

East Lansing : Site Reference ID/Investigator# 78950

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

View More »

Farmington Hills : Site Reference ID/Investigator# 79278

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Grand Rapids : Site Reference ID/Investigator# 79397

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Grand Rapids :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Grand Rapids :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Grand Rapids : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Grand Rapids :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Minneapolis : University of Minnesota

A Study of Sweat Testing Using a Quantitative Patch

Minneapolis : Site Reference ID/Investigator# 76791

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Minneapolis : Site Reference ID/Investigator# 79253

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Minneapolis : University of Minnesota - Cystic Fibrosis Center

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Kansas City : Site Reference ID/Investigator# 78948

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Kansas City :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Kansas City : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Kansas City :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

St. Louis : Site Reference ID/Investigator# 79275

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

View More »

St. Louis :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Omaha : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Omaha :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Las Vegas : Children's Lung Specialists

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Bedford : Dartmouth Hitchcock Specialty Care Clinic

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Lebanon : Dartmouth Hitchcock Medical Center

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Manchester : Site Reference ID/Investigator# 78957

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Long Branch : Site Reference ID/Investigator# 78901

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Long Branch : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Morristown : Site Reference ID/Investigator# 76782

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Albuquerque : UNM Clinical and Translational Center

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Great Neck : Biomedical Research Alliance of New York

Cystic Fibrosis - Pediatric

New Hyde Park : Biomedical Research Alliance of New York

Cystic Fibrosis

View More »

Albany :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Buffalo : Women and Children's Hospital of Buffalo

I Change Adherence & Raise Expectations

Buffalo : Site Reference ID/Investigator# 78941

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

New Hyde Park : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

New Hyde Park :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

New York : Site Reference ID/Investigator# 76773

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

New York :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Rochester : University of Rochester Medical Center

I Change Adherence & Raise Expectations

Rochester : Site Reference ID/Investigator# 92713

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Syracuse : Site Reference ID/Investigator# 78912

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Syracuse : SUNY Upstate University

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Syracuse :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Valhalla :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Chapel Hill : UNC-Chapel Hill

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Chapel Hill : Site Reference ID/Investigator# 78937

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Chapel Hill : UNC Hospitals

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

Chapel Hill : UNC at Chapel Hill

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Chapel Hill :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

View More »

Chapel Hill : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Durham : Duke University Medical Center

I Change Adherence & Raise Expectations

Durham : Duke University Medical Center

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

Bismarck : St. Alexius Medical Center

A study for cystic fibrosis patients who might have a condition called Fibrosing Colonopathy (FC).

View More »

Bismark : Site Reference ID/Investigator# 78958

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Akron : Akron Children's Hospital

I Change Adherence & Raise Expectations

Akron : Site Reference ID/Investigator# 79263

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Cincinnati : Site Reference ID/Investigator# 79375

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Cincinnati : Cincinnati Children's Hospital

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Cincinnati : UC Health - University of Cincinnati

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

View More »

Cincinnati : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Cincinnati :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Cleveland : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Cleveland : Rainbow Babies and Children's Hospital

I Change Adherence & Raise Expectations

Cleveland :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Columbus : Nationwide Children's Hospital

I Change Adherence & Raise Expectations

Columbus : Site Reference ID/Investigator# 78897

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Columbus : Nationwide Children's Hospital, Ohio State University

Prevention of Cystic Fibrosis Diabetes

Columbus : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Columbus : Nationwide Children's Hospital

Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)

Dayton : Site Reference ID/Investigator# 78915

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Dayton :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Toledo : Toledo Children's Hospital

I Change Adherence & Raise Expectations

Toledo : Site Reference ID/Investigator# 78913

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Toledo :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Oklahoma City : Santiago Reyes, MD

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Oklahoma City : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Oklahoma City :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Hershey : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Hershey :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Philadelphia : Site Reference ID/Investigator# 76777

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Philadelphia :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Pittsburgh :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

View More »

Pittsburgh : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Pittsburgh :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Charleston : Medical University of South Carolina

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Charleston : Medical University of South Carolina

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Charleston :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Charleston : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Charleston :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

View More »

Washington :

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

Sioux Falls :

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

Sioux Falls : Site Reference ID/Investigator# 78909

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Memphis : Children's Foundation Research Institute/UTHSC

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Nashville :

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

Nashville :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Austin : Site Reference ID/Investigator# 79213

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Dallas :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Dallas :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Fort Worth : Site Reference ID/Investigator# 78949

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Fort Worth :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

View More »

Houston :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

San Antonio :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Tyler : Site Reference ID/Investigator# 79261

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Salt Kale City : Primary Children's Medical Center

I Change Adherence & Raise Expectations

Salt Lake City : University of Utah

A Study of Sweat Testing Using a Quantitative Patch

Salt Lake City :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Salt Lake City :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Salt Lake City : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Colchester : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Charlottesville : Site Reference ID/Investigator# 78942

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Charlottesville : University of Virginia

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Norfolk : Site Reference ID/Investigator# 79293

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Richmond : Site Reference ID/Investigator# 78955

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Richmond :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Seattle : Seattle Children's Hospital

I Change Adherence & Raise Expectations

Seattle :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Seattle : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Spokane : Site Reference ID/Investigator# 79257

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Morgantown : West Virginia University

I Change Adherence & Raise Expectations

Morgantown : Site Reference ID/Investigator# 78953

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Morgantown :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Madison : American Family Children's Hospital

A Study of Sweat Testing Using a Quantitative Patch

Madison : Site Reference ID/Investigator# 78944

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Madison :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Milwaukee : Site Reference ID/Investigator# 79294

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Milwaukee : Childrens Hospital of Wisconsin

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

View More »

Milwaukee :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Buenos Aires : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Paraná Entre Ríos : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Clayton : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

New Lambton Heights : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Parkville : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Antwerp : University Hospital Antwerp - Universitair Ziekenhuis Antwerpen (UZA)

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Pleven : Clinic of Paediatric Diseases at UMHAT Dr Georgi Stranski

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Plovdiv : Clinic of Genetic and Paediatric Diseases at UMHAT Sveti Georgi

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Ruse : Specialized Hospital for Active Treatment of Pulmological and Phtisiatric Disease

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Varna : Multiprofile Clinic for Specialized Pediatric Clinic at MHAT Sveta Marina

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Calgary : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Halifax : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Montreal : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Montreal : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Toronto : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

View More »

Toronto : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Vancouver : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Winnipeg : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Bron : Centre de ressources et de compétences pour la mucovisidose, enfants

Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus®

Lyon : Centre de Ressource et de Compétence Mucoviscidose Pédiatrique Centre de Référence Mucoviscidose

Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis

Berlin : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Bochum : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Bochum : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Dresden : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Erlangen : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

View More »

Essen : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Frankfurt : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Frankfurt : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Frankfurt : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Hannover : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Jena : Jena University Hospital, Universitaetsklinikum Jena

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Jena : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Koeln : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Koln : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

München : Klinikum der Universitat Munchen Medizinische Klinik-Innenstadt

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Munich : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Tubingen : University Children's Clinic Tubingen

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Patras : Novartis Investigative site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Thessaloniki : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Budapest : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Debrecen : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Kaposvar : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Szeged : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Firenze : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Messina : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Napoli : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Roma : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Kagawa : Site Reference ID/Investigator# 65530

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Kagoshima : Site Reference ID/Investigator# 65527

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Kanazawa : Site Reference ID/Investigator# 65529

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Nagoya : Site Reference ID/Investigator# 73813

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Nagoya : Site reference ID/Investigator # 96698

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

View More »

Obu : Site reference ID/Investigator # 93736

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Sendai : Site Reference ID/Investigator# 65528

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Tokyo : Site Reference ID/Investigator# 67122

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Tsukuba : Site Reference ID/Investigator# 88673

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Tsukuba : Site reference ID/Investigator # 93735

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Monterrey : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Gdansk : Specjalistyczny Zespół Opieki Zdrowotnej nad Matką i Dzieckiem Poradnia Leczenia Mukowiscydozy

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Gdansk : Specjalistyczny Zespot Opieki Zdrowotnej nad Matka i Dzieckiem Poradnia Leczenia Mukowiscydozy

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Karpacz : Centrum Pulmonologii i Alergologii w Karpaczu

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Lodzi : Wojewodzki Szpital Specjalistyczny im Kopernika

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Lublin : Dziecięcy Szpital Kliniczny im. Prof. Antoniego Gębali

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

View More »

Lublin : ALERGOTEST s.c Specjalistyczne Centrum Medyczne

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Poznan : Szpital Kliniczny im Karola Jonschera

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Poznan : Szpital Kliniczny im Karola Jonschera

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Rabka Zdrój : NZOZ Sanatorium Cassia Villa Medica

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Rabka Zdrój : NZOZ Sanatorium Cassia Villa Medica

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Rzeszow : NZOZ Podkarpacki Osrodek Pulmonologii i Alergologii

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Rzeszow : NZOZ Podkarpacki Osrodek Pulmonologii i Alergologii

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Warszawa : IRMED Irena Wojciechowska

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Warszawa : Centrum Zdrowia Matki, Dziecka i Mlodziezy

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Doha : Hamad Medical Corporation

Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)

Kazan : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Moscow : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Voronezh : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Yaroslavl : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Barcelona : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Sabadell : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Valencia : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Lausanne : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Zurich : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Belfast : Celerion

A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis

Belfast :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Cambridge : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Cardiff : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Edinburgh :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

View More »

Liverpool : Liverpool Heart & Chest Hospital

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis

Liverpool : Liverpool Heart and Chest Hospital

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

London : Royal Brompton Hospital, Department of Respiratory Medicine

Extension Study of Arikace™ in CF Patients With Chronic Pseudomonas Aeruginosa Infection

Sheffield : Sheffield Children's Hospital, The Academic Unit of Child Health

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.